Ascidian to Launch Clinical Trial for Stargardt Disease RNA Editing Therapy

Feb 1, 2024 | Featured, Maryland, News, Science

Ascidian Therapeutics has received authorization from the US Food & Drug Administration to launch a Phase ½ clinical trial for ACDN-01, the company’s RNA editing therapy for people with Stargardt disease, an inherited form of macular degeneration caused by...

Artistry of Wine

Dec 1, 2023

Indulge in an evening of sophistication at Artistry of Wine. Join us for a refined wine-tasting experience, exquisite art displays, and support our mission in battling vision loss.

VISIONS 2024

Dec 1, 2023

VISIONS 2024 invites you to join a gathering of innovators, advocates, and researchers in the field of vision health. This convention aims to discuss breakthroughs, share knowledge, and promote collaboration in the fight against blindness.

17th Annual Kansas City VisionWalk

Dec 1, 2023

Join us at the 17th Annual Kansas City VisionWalk for a day of advocacy and unity. Walk in solidarity with the visually impaired community and help pave the way towards a brighter future.

18th Annual Fort Wayne VisionWalk

Dec 1, 2023

Participate in the 18th Annual Fort Wayne VisionWalk and become a beacon of hope for the visually impaired. Your involvement supports life-changing research and community initiatives.

16th Annual Cleveland VisionWalk

Dec 1, 2023

Join the movement at the 16th Annual Cleveland VisionWalk. Walk alongside supporters and volunteers to raise funds and bring hope to those affected by vision impairment.